이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2026. 5. 1.1 분 읽기
Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is establishing a public docket entitled "Obesity and Drug Dosing: Clinical Pharmacology Considerations." The Agency is soliciting input from interested persons on assessing the effect of obesity on drug pharmacokinetics and pharmacodynamics during drug (including biological product) development. These assessments could potentially inform whether obesity impacts the safety and effectiveness of the drug and dosing recommendations for obese patients.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →